Search

everythinglearnresearchcommunity

for

Search:↓

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

Bone-marrow and epidermal stem cells help heal wounds differently, with bone-marrow cells aiding in blood vessel formation and epidermal cells in hair growth.

CE-PTG is a better method for analyzing hair growth in androgenetic alopecia.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

The document concludes that measuring γ-glutamyl transpeptidase activity is more accurate with a higher substrate concentration and using diluted acetic acid to stop the reaction.

A CCS patient with severe complications was successfully treated using combined therapies.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated for treating androgenetic alopecia.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

CTE can distort results in hair growth trials, so exclude it carefully.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated.

Total testosterone levels can help diagnose androgen-producing tumors and hyperandrogenism in women.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

CGF treatment effectively and safely improves hair loss in androgenic alopecia patients.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Daily subcutaneous testosterone effectively restores testosterone levels in men.